Search

everythinglearnresearchcommunity

for

Search:↓

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Heat and chemicals improve finasteride delivery to scalp and hair follicles, potentially enhancing treatment for hair loss.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Air Vice-Marshal Sir Ralph Jackson significantly advanced dialysis technology in the UK.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Uterine transplants for transgender women are feasible but need more research.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Feminizing hormone therapy increases kidney filtration rate.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.